BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Thompson CS. Diabetic nephropathy: Treatment with phosphodiesterase type 5 inhibitors. World J Diabetes 2013; 4(4): 124-129 [PMID: 23961322 DOI: 10.4239/wjd.v4.i4.124]
URL: https://www.wjgnet.com/1948-9358/full/v4/i4/124.htm
Number Citing Articles
1
Yan Shang, Abubucker Peer Mohideen. Purpurin, a Natural Anthroquinone Ameliorates Streptozotocin-induced Diabetic Nephropathy via Attenuating Hyperglycemia, Dyslipidemia, and Inflammation in RatsPharmacognosy Magazine 2023; 19(2): 461 doi: 10.1177/09731296231158477
2
Qiang Jia, Rui Yang, Xiao‑Fen Liu, Shan‑Feng Ma, Lei Wang. Genistein attenuates renal fibrosis in streptozotocin‑induced diabetic ratsMolecular Medicine Reports 2018;  doi: 10.3892/mmr.2018.9635
3
Yong-xian Shao, Manna Huang, Wenjun Cui, Ling-Jun Feng, Yinuo Wu, Yinghong Cai, Zhe Li, Xinhai Zhu, Peiqing Liu, Yiqian Wan, Hengming Ke, Hai-Bin Luo. Discovery of a Phosphodiesterase 9A Inhibitor as a Potential Hypoglycemic AgentJournal of Medicinal Chemistry 2014; 57(24): 10304 doi: 10.1021/jm500836h
4
Linda S. Hoffmann, Christopher J. Larson, Alexander Pfeifer. Metabolic ControlHandbook of Experimental Pharmacology 2015; 233: 283 doi: 10.1007/164_2015_3
5
Mark McCarty. Supplementation with Phycocyanobilin, Citrulline, Taurine, and Supranutritional Doses of Folic Acid and Biotin—Potential for Preventing or Slowing the Progression of Diabetic ComplicationsHealthcare 2017; 5(1): 15 doi: 10.3390/healthcare5010015
6
Arif Ul Hasan, Wararat Kittikulsuth, Fuminori Yamaguchi, Tuba Musarrat Ansary, Asadur Rahman, Yuki Shibayama, Daisuke Nakano, Hirofumi Hitomi, Masaaki Tokuda, Akira Nishiyama. IBMX protects human proximal tubular epithelial cells from hypoxic stress through suppressing hypoxia-inducible factor-1α expressionExperimental Cell Research 2017; 358(2): 343 doi: 10.1016/j.yexcr.2017.07.007
7
N. Suganya, E. Bhakkiyalakshmi, D. V. L. Sarada, K. M. Ramkumar. Reversibility of endothelial dysfunction in diabetes: role of polyphenolsBritish Journal of Nutrition 2016; 116(2): 223 doi: 10.1017/S0007114516001884
8
Mark F. McCarty. In type 1 diabetics, high-dose biotin may compensate for low hepatic insulin exposure, promoting a more normal expression of glycolytic and gluconeogenic enyzymes and thereby aiding glycemic controlMedical Hypotheses 2016; 95: 45 doi: 10.1016/j.mehy.2016.08.002
9
Ryan Varghese, Gargi Digholkar, Jainam Karsiya, Sahil Salvi, Jeenam Shah, Dileep Kumar, Rohit Sharma. PDE5 inhibitors: breaking new grounds in the treatment of COVID-19Drug Metabolism and Personalized Therapy 2024; 38(4): 295 doi: 10.1515/dmpt-2023-0011
10
Jingxue Han, Xinwei Wang, Jingyi Hou, Yu Liu, Peng Liu, Tingting Zhao, Kazim Husain. Using Network Pharmacology to Explore the Mechanism of Peach Kernel-Safflower in the Treatment of Diabetic NephropathyBioMed Research International 2021; 2021: 1 doi: 10.1155/2021/6642584
11
Ryan Varghese, Gargi Digholkar, Jainam Karsiya, Sahil Salvi, Jeenam Shah, Dileep Kumar, Rohit Sharma. PDE5 inhibitors: breaking new grounds in the treatment of COVID-19Drug Metabolism and Personalized Therapy 2023;  doi: 10.1515/dmdi-2023-0011